NewGenIvf Group (NIVF) Expected to Release Earnings on Tuesday

NewGenIvf Group (NASDAQ:NIVF) will likely be releasing its results before the market opens on Tuesday, June 30th. Analysts expect NewGenIvf Group to post earnings of $185.40 per share and revenue of $2.8720 million for the quarter.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The business had revenue of $1.42 million during the quarter. On average, analysts expect NewGenIvf Group to post $5 EPS for the current fiscal year and $9 EPS for the next fiscal year.

NewGenIvf Group Stock Down 11.3%

NASDAQ:NIVF opened at $0.67 on Tuesday. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. The business has a fifty day simple moving average of $1.24 and a two-hundred day simple moving average of $4.27. NewGenIvf Group has a 1 year low of $0.47 and a 1 year high of $372.00.

Insider Buying and Selling

In other NewGenIvf Group news, major shareholder Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average cost of $0.99 per share, for a total transaction of $136,165.59. Following the purchase, the insider owned 111,885 shares of the company’s stock, valued at approximately $110,766.15. This represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 31.80% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.